Interferon-alfa sensitivity biomarkers

Details for Australian Patent Application No. 2010236606 (hide)

Owner Schering Corporation

Inventors Yver, Antoine Jean

Agent Spruson & Ferguson

Pub. Number AU-A-2010236606

PCT Pub. Number WO2010/120759

Priority 61/169,235 14.04.09 US

Filing date 13 April 2010

Wipo publication date 21 October 2010

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/120759 Priority application(s): WO2010/120759

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236613-Engineered botulinum neurotoxin

2010236602-Bioavailable capsule compositions of amorphous alpha- (N-sulfonamido)acetamide compound